Citation: | ZHANG Sheng, CAO Jun, JIN Jieyu, LIANG Yuting. Research progress on molecular biological characteristics of IgG subclasses and its clinical application in related diseases[J]. Chinese Journal of General Practice, 2023, 21(11): 1932-1935. doi: 10.16766/j.cnki.issn.1674-4152.003261 |
[1] |
ROOPENIAN D C, AKILESH S. FcRn: the neonatal Fc receptor comes of age[J]. Nat Rev Immunol, 2007, 7(9): 715-725. doi: 10.1038/nri2155
|
[2] |
NAPODANO C, MARINO M, STEFANILE A, et al. Immunological role of IgG subclasses[J]. Immunol Invest, 2021, 50(4): 427-444. doi: 10.1080/08820139.2020.1775643
|
[3] |
LUDWIG-KRAUS B, KRAUS F B. Similar but not consistent: revisiting the pitfalls of measuring IgG subclasses with different assays[J]. J Clin Lab Anal, 2017, 31(6): e22146. DOI: 10.1002/jcla.22146.
|
[4] |
LIU Z J, DENG C W, LI P, et al. A reference interval for serum IgG subclasses in Chinese children[J]. PLoS One, 2018, 13(3): e0192923. DOI: 10.1371/journal.pone.0192923.
|
[5] |
LADWIG P M, BARNIDGE D R, SNYDER M R, et al. Quantification of serum IgG subclasses by use of subclass-specific tryptic peptides and liquid chromatography: tandem mass spectrometry[J]. Clin Chem, 2014, 60(8): 1080-1088. doi: 10.1373/clinchem.2014.222208
|
[6] |
SIGAL L H. Basic science for the clinician 58: IgG subclasses[J]. J Clin Rheumatol, 2012, 18(6): 316-318. doi: 10.1097/RHU.0b013e318269446b
|
[7] |
BONDT A, HOEK M, TAMARA S, et al. Human plasma IgG1 repertoires are simple, unique, and dynamic[J]. Cell Syst, 2021, 12(12): 1131-1143. doi: 10.1016/j.cels.2021.08.008
|
[8] |
SCHUR P H. IgG subclasses: a review[J]. Ann Allergy, 1987, 58(2): 89-96, 99.
|
[9] |
BARTON J, BARTON C, BERTOLI L. Duration of frequent or severe respiratory tract infection in adults before diagnosis of IgG subclass deficiency[J]. PLoS One, 2019, 14(5): e0216940. DOI: 10.1371/journal.pone.0216940.
|
[10] |
MOLICA S. Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment[J]. Leuk Lymphoma, 1994, 13(3-4): 203-214. doi: 10.3109/10428199409056283
|
[11] |
CRASSINI K R, ZHANG E, BALENDRAN S, et al. Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in chronic lymphocytic leukaemia[J]. Br J Haematol, 2018, 181(1): 97-101. doi: 10.1111/bjh.15146
|
[12] |
PASTORI C, GALLI L, SIRACUSANO G, et al. Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients[J]. AIDS, 2021, 35(10): 1549-1559. doi: 10.1097/QAD.0000000000002944
|
[13] |
ZHANG H Z, LI P, WU D, et al. Serum IgG subclasses in autoimmune diseases[J]. Medicine (Baltimore), 2015, 94(2): e387. DOI: 10.1097/MD.0000000000000387.
|
[14] |
BASILE U, MARINO M, NAPODANO C, et al. Serological immunoglobulin-free light chain profile in myasthenia gravis patients[J]. J Immunol Res, 2018: 9646209. DOI: 10.1155/2018/9646209.
|
[15] |
BARTON J C, BARTON J C, BERTOLI L F, et al. Characterization of adult patients with IgG subclass deficiency and subnormal IgG2[J]. PLoS One, 2020, 15(10): e0240522. DOI: 10.1371/journal.pone.0240522.
|
[16] |
LEITAO FILHO F S, RA S W, MATTMAN A, et al. Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD[J]. Respir Res, 2018, 19(1): 30. doi: 10.1186/s12931-018-0733-z
|
[17] |
YAMAZAKI R, KATO J, KODA Y, et al. Impact of immunoglobulin G2 subclass level on late-onset bacterial infection after allogeneic hematopoietic stem cell transplantation[J]. Transpl Infect Dis, 2019, 21(3): e13086. DOI: 10.1111/tid.13086.
|
[18] |
YAMAZAKI R, KIKUCHI T, KATO J, et al. Recurrent bacterial pneumonia due to immunoglobulin G2 subclass deficiency after allogeneic hematopoietic stem cell transplantation: efficacy of immunoglobulin replacement[J]. Transpl Infect Dis, 2018, 20(3): e12863. DOI: 10.1111/tid.12863.
|
[19] |
XIE L D, GAO Y, LI M R, et al. Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto ' s thyroiditis with different thyroid functional status[J]. Clin Exp Immunol, 2008, 154(2): 172-176. doi: 10.1111/j.1365-2249.2008.03756.x
|
[20] |
KAWANO Y, NOMA T, YATA J. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2[J]. J Immunol, 1994, 153(11): 4948-4958.
|
[21] |
ENGELHART S, GLYNN R J, SCHUR P H. Disease associations with isolated elevations of each of the four IgG subclasses[J]. Semin Arthritis Rheum, 2017, 47(2): 276-280. doi: 10.1016/j.semarthrit.2017.03.021
|
[22] |
HUSSAIN R, JAFERI W, ZUBERI S, et al. Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome[J]. Am J Trop Med Hyg, 1997, 56(3): 301-306. doi: 10.4269/ajtmh.1997.56.301
|
[23] |
VIDARSSON G, DEKKERS G, RISPENS T. IgG subclasses and allotypes: from structure to effector functions[J]. Front Immunol, 2014, 5: 520. DOI: 10.3389/fimmu.2014.00520.
|
[24] |
ZENG Y L, ZHANG Y, CHEN Q G, et al. Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus[J]. Lupus, 2021, 30(6): 901-912. doi: 10.1177/0961203321995242
|
[25] |
GULLI F, BASILE U, GRAGNANI L, et al. IgG cryoglobulinemia[J]. Eur Rev Med Pharmacol Sci, 2018, 22(18): 6057-6062.
|
[26] |
GULLI F, BASILE U, GRAGNANI L, et al. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders[J]. Dig Liver Dis, 2016, 48(8): 927-933.
|
[27] |
RIGOPOULOU E I, DAVIES E T, BOGDANOS D P, et al. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis[J]. Liver Int, 2007, 27(9): 1226-1231. doi: 10.1111/j.1478-3231.2007.01586.x
|
[28] |
RIGOPOULOU E I, DAVIES E T, PARES A, et al. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis[J]. Gut, 2005, 54(4): 528-532. doi: 10.1136/gut.2003.036558
|
[29] |
KONECZNY I. Update on IgG4-mediated autoimmune diseases: new insights and new family members[J]. Autoimmun Rev, 2020, 19(10): 102646. DOI: 10.1016/j.autrev.2020.102646.
|
[30] |
TAKAHASHI H, YAMAMOTO M, SUZUKI C, et al. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity[J]. Autoimmun Rev, 2010, 9(9): 591-594. doi: 10.1016/j.autrev.2010.05.003
|
[31] |
SHIMOSEGAWA T, CHARI S T, FRULLONI L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology[J]. Pancreas, 2011, 40(3): 352-358. doi: 10.1097/MPA.0b013e3182142fd2
|
[32] |
UMEHARA H, OKAZAKI K, KAWANO M, et al. How to diagnose IgG4-related disease[J]. Ann Rheum Dis, 2017, 76(11): e46. DOI: 10.1136/annrheumdis-2017-211330.
|
[33] |
DEMIR A M, AYDIN F, ACAR B, et al. IgG4-related disease and ANCA positive vasculitis in childhood: a case-based review[J]. Clin Rheumatol, 2021, 40(9): 3817-3825. doi: 10.1007/s10067-021-05635-5
|
[34] |
MICHAILIDOU D, SCHWARTZ D M, MUSTELIN T, et al. Allergic aspects of IgG4-related disease: implications for pathogenesis and therapy[J]. Front Immunol, 2021, 12: 693192. DOI: 10.3389/fimmu.2021.693192.
|
[35] |
MÍNGUEZ SABATER A, LADRÓN ABIA P, HIGÓN BALLESTER M D. IgG4 autoimmune sclerosing cholangitis[J]. Med Clin (Barc), 2021, 156(8): 414-415. doi: 10.1016/j.medcli.2020.01.010
|
[36] |
ARYASIT O, TIRASET N, PREECHAWAI P, et al. IgG4-related disease in patients with idiopathic orbital inflammation[J]. BMC Ophthalmol, 2021, 21(1): 356. doi: 10.1186/s12886-021-02115-x
|
[37] |
MOMONIAT T, JACOB D, DUHLI N, et al. IgG4-related tubulointerstitial nephritis[J]. BMJ Case Rep, 2021, 14(11): e241942. DOI: 10.1136/bcr-2021-241942.
|
[38] |
CHEN L F, MO Y Q, MA J D, et al. Elevated serum IgG4 defines specific clinical phenotype of rheumatoid arthritis[J]. Mediators Inflamm, 2014, 2014: 635293. DOI: 10.1155/2014/635293.
|
[39] |
SAKTHISWARY R, SHAHARIR S S, WAHAB A A. Frequency and clinical significance of elevated IgG4 in rheumatoid arthritis: a systematic review[J]. Biomedicines, 2022, 10(3): 558. doi: 10.3390/biomedicines10030558
|
[40] |
KOERS J, DERKSEN N, FALKENBURG W, et al. Elevated Fab glycosylation of anti-hinge antibodies[J]. Scand J Rheumatol, 2021, 11: 1-8.
|